ARCHIVES

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

This article is from The Cancer Letter archive.

Vol. 38 No. 44 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Univ. Of Washington, Fox Chase, ICC Win CCRU, CCSP Awards

July 8, 1983

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994